{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-055046","form_type":"8-K","ticker":null,"cik":"0001831874","company_name":"Iris Acquisition Corp","filed_at":"2023-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.985772+00:00","generated_at":"2026-06-16T03:48:06.660904+00:00","sec_items":["3.01","5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Iris Acquisition Corp director resigns, triggering Nasdaq audit committee non-compliance","bullets":["Dr. Shahibhushan Borade resigned from the board effective April 26, 2023, with no dispute regarding operations or policies.","Resignation caused the audit committee to fall below the required three independent directors, violating Nasdaq Rule 5605(c)(2)(A).","Company notified Nasdaq on May 2, 2023, and intends to cure the deficiency within the applicable cure period."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-055046","json":"https://secwatch.observer/filing/0001104659-23-055046.json","markdown":"https://secwatch.observer/filing/0001104659-23-055046.md","text":"https://secwatch.observer/filing/0001104659-23-055046.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831874/000110465923055046/0001104659-23-055046-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831874/000110465923055046/tm2314403d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T03:48:06.660904+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3a6670bde253a9b6667f24d648c80de900b055b5","claim":"Iris Acquisition Corp received a nasdaq deficiency notice notice regarding other.","evidence_excerpt":"May 2, 2023, Iris Acquition Corp (the “Company”) notified the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that as a result of the resignation of Shahibhushan Borade (“Dr. Borade”) from the Company’s board of directors (the “Board”) (as described below in","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831874/000110465923055046/0001104659-23-055046-index.htm","confidence":0.7,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"}],"fact_type":"exchange_compliance_notice"},{"claim_id":"b3849de7ad","claim":"Dr. Shahibhushan Borade resigned as Director at Iris Acquisition Corp.","evidence_excerpt":"On April 26, 2023, Dr. Borade, an Audit Committee member, notified the Company of his intent to resign as a member of the Board effective April 26, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831874/000110465923055046/0001104659-23-055046-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}